Clinical Trials Browser

Phase 2 × INDUSTRY × Gliosarcoma × Clear all

Glioblastoma, Gliosarcoma

NCT02798406 2021-07-15

CAPTIVE

Brain Neoplasms, Disease, Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue, Nervous System Diseases, Neuroectodermal Tumors, Neoplasms, Neuroepithelial, Gliosarcoma

NCT01498328 2020-02-17

ReACT

Phase 2 Completed

127 enrolled

CNSSarcoma

Brain Neoplasms, Glioblastoma, Neoplasms, Recurrence, Gliosarcoma

NCT00814593 2019-05-10

Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery

Phase 2 Withdrawn

CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT01124539 2014-12-09

Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

Phase 2 Unknown

58 enrolled

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT00004200 2012-08-08

Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Phase 2 Completed

CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00114309 2009-04-03

131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma

Phase 2 Unknown

66 enrolled

CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma

Clinical Trials

ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme

CAPTIVE

ReACT

Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery

Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma